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Abstract
Background:  The  rheumatoid  arthritis  is  a  clinical  entity  capable  to  cause  hearing  impairment
that can  be  diagnosed  promptly  with  high  frequencies  audiometry.
Objective:  To  detect  subclinical  sensorineural  hearing  loss  in  patients  with  rheumatoid  arthritis.
Material and  methods: Cross-sectional  study  on  patients  with  rheumatoid  arthritis  performing
high frequency  audiometry  125  Hz  to  16,000  Hz  and  tympanometry.  The  results  were  correlated
with markers  of  disease  activity  and  response  to  therapy.
Results:  High  frequency  audiometry  was  performed  in  117  female  patients  aged  from  19  to  65
years. Sensorineural  hearing  loss  was  observed  at  a  sensitivity  of  pure  tones  from  125  to  8000  Hz
in 43.59%,  a  tone  threshold  of  10,000  to  16,000  Hz  in  94.02%  patients  in  the  right  ear  and  in
95.73% in  the  left  ear.  Hearing  was  normal  in  8  (6.84%)  patients.  Hearing  loss  was  observed  in
109 (93.16%),  and  was  asymmetric  in  36  (30.77%),  symmetric  in  73  (62.37%),  bilateral  in  107
(91.45%), unilateral  in  2  (1.71%),  and  no  conduction  and/or  mixed  hearing  loss  was  encountered.
Eight (6.83%)  patients  presented  vertigo,  24  (20.51%)  tinnitus.  Tympanogram  type  A  presented
in 88.90%  in  the  right  ear  and  91.46%  in  the  left  ear,  with  5.98--10.25%  type  As.  Stapedius  reﬂex
was present  in  75.3--85.2%.  Speech  discrimination  in  the  left  ear  was  signiﬁcantly  different
(p =  0.02)  in  the  group  older  than  50  years.  No  association  was  found  regarding  markers  of
disease activity,  but  there  was  an  association  with  the  onset  of  rheumatoid  arthritis  disease.
 Please cite this article as: Trevin˜o-González JL, Villegas-González MJ, Mun˜oz-Maldonado GE, Montero-Cantu CA, Nava-Zavala AH, Garza-
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Utility  high-frequency  audiometry  365
Conclusions:  Patients  with  rheumatoid  arthritis  had  a  high  prevalence  of  sensorineural  hearing
loss for  high  and  very  high  frequencies.
©  2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
PALABRAS  CLAVE
Hipoacusia
neurosensorial;
Audiometría  de  altas
frecuencias;
Artritis  reumatoide
Hipoacusia  neurosensorial  subclínica  en  pacientes  femeninas  con  artritis  reumatoide
Resumen
Antecedentes:  La  artritis  reumatoide  es  una  entidad  clínica  capaz  de  ocasionar  hipoacusia  neu-
rosensorial,  pudiendo  ser  diagnosticada  oportunamente  con  audiometría  de  altas  frecuencias.
Objetivo: Detectar  hipoacusia  neurosensorial  subclínica  en  pacientes  con  artritis  reumatoide.
Material y  métodos:  Estudio  transversal  en  pacientes  con  artritis  reumatoide,  donde  se  realiza
audiometría  de  hasta  altas  frecuencias  de  125-16,000  Hz  y  timpanometría.  Los  resultados  fueron
correlacionados  con  marcadores  de  actividad  de  la  enfermedad  y  la  respuesta  al  tratamiento.
Resultados:  Se  realizó  audiometría  particularmente  de  altas  frecuencias  en  117  pacientes
femeninas  con  edad  de  19-65  an˜os.  La  hipoacusia  neurosensorial  fue  observada  a  una  sensi-
bilidad de  tonos  puros  de  125-8000  Hz  en  el  43.59%  y  umbrales  de  tonos  de  10,000-16,000  Hz  en
el 94.02%  de  los  pacientes  en  oído  derecho  y  en  el  95.73%  en  oído  izquierdo.  Audición  normal
en 8  (6.84%)  pacientes,  hipoacusia  en  109  (93.16%),  asimétrica  en  36  (30.77%),  simétrica  en
73 (62.37%),  bilateral  en  107  (91.45%)  y  unilateral  en  2  (1.71%);  no  encontramos  hipoacusia
de conducción  o  mixta.  Ocho  (6.83%)  pacientes  cursaron  con  vértigo,  24  (20.51%)  con  tinitus.
Timpanograma  tipo  A  presente  en  el  88.90%  en  oído  derecho  y  en  el  91.46%  en  oído  izquierdo,  el
5.98-10.25%  tipo  As;  reﬂejo  estapedial  en  el  75.3-85.2%.  Hubo  diferencia  signiﬁcativa  (p  =  0.02)
en discriminación  del  lenguaje  en  oído  izquierdo  en  mayores  de  50  an˜os.  No  encontramos  aso-
ciación con  marcadores  de  actividad  de  la  enfermedad.  Se  observó  asociación  con  el  inicio  de
la artritis  reumatoide.
Conclusiones:  Los  pacientes  con  artritis  reumatoide  tienen  alta  prevalencia  de  hipoacusia  neu-
rosensorial  para  altas  frecuencias.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Autoimmune  sensorineural  hearing  loss  or  immune-mediated
inner  ear  disease  was  described  by  McCabe  in  1979  and
has  been  the  subject  of  clinical  and  experimental  research
over  the  last  2  decades.1,2 It  presents  in  under  1%  of  all
auditory  and  vestibular  impairment;  it  is  characteristically
bilateral,  ﬂuctuating  and  progressive  over  weeks  or  months,
and  responds  to  corticosteroids.3
Several  tests  which  detect  auto-antibodies  and  speciﬁc
antibodies  against  inner  ear  cochlear  membrane  antigens
have  been  described,  with  somewhat  unsatisfactory  study
results.4--6 No  tests  were  conducted  in  this  study  as  it  was
considered  that  the  ability  to  detect  early  sensorineural
hearing  loss  with  very  high  frequency  audiometry  could
be  relevant.  Since  vestibular  tests  were  non-speciﬁc  for
autoimmune  problems,  they  were  not  included  in  this  study.
Rheumatoid  arthritis  is  a  chronic  inﬂammatory  disease
characterised  by  oedema  and  destruction  of  the  joint’s
synovial  membrane,  leading  to  severe  disability  and  prema-
ture  death.7 Extra-articular  manifestations  of  rheumatoid
arthritis  include:  skin,  eyes,  heart,  lung  and  hearing  alter-
ations  leading  to  sensorineural  hearing  loss  through  inner
a
o
m
Oar  involvement  up  to  24--60%  in  high  frequencies  of
000--8000  Hz.8 Due  to  it  being  an  auto-immune  disorder,
ne  extra-articular  manifestation  can  be  sensorineural  hear-
ng  loss.9 it  is  frequently  taken  for  granted  that  the  patient
equires  several  drugs  which  could  be  potentially  ototoxic.10
nﬂammatory  arthritis  of  the  incudostapedial  and  incudoma-
leolar  joint  may  present  in  the  middle  ear  causing  stiffness
n  the  sound  transmission  mechanism.11
Öztürk  et  al.12 demonstrated  that  sensorineural  hear-
ng  loss  presenting  in  patients  with  rheumatoid  arthritis  is
igniﬁcant  in  high  frequencies,  associating  it  with  neuritis,
asculitis,  ototoxicity  of  medication  used  for  the  rheumatoid
rthritis  and  the  length  of  the  disease.
The  aim  of  our  study  was  to  conduct  audiometric
ssessment  of  the  cochlear  function  as  a  whole  and  more
peciﬁcally  in  high  frequencies  in  a  female  population
ith  rheumatoid  arthritis.  The  references  contain  reports
n  studies  conducted  with  conventional  audiometry  tests
hich  fail  to  measure  thresholds  of  10,000--16,000  Hz  and
re  unable  to  detect  the  existence  of  injury  in  this  area
f  the  cochlear  when  it  is  possible  that  early  detection
ay  alter  its  development,  as  reported  by  Conway  et  al.13
ur  study  also  aimed  at  describing  the  characteristics  and
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everity  of  sensorineural  hearing  loss  and  its  subsequent  risk
actors  whilst  playing  a  part  in  early  subclinical  detection
f  hearing  loss.
aterial and methods
n  observational,  cross-sectional  and  analytical  study  was
onducted  in  an  exclusively  female  population  of  117
atients  aged  between  19  and  65  who  had  been  diagnosed
ith  rheumatoid  arthritis,  according  to  the  internationally
onsensured  project  criteria,  also  known  as  EULAR/ACR  2010
aimed  at  standardising  epidemiological  therapeutic  crite-
ia  and  results)  in  the  Rheumatology  and  ENT  Services  of
he  University  Hospital.  Although  the  study  was  conducted
n  an  open  population  of  119  patients,  only  2  were  male  and
t  was  therefore  decided  to  exclude  them  from  the  study.
 complete  medical  history  and  thorough  physical  examina-
ion  were  made,  and  the  following  patients  were  excluded
rom  the  study:  those  with  a  history  of  hearing  loss  under
4  h;  those  who  presented  with  barotrauma,  brain  trauma
r  otic  trauma;  those  diagnosed  with  Meniere’s  disease,
coustic  trauma,  otosclerosis,  chronic  otitis  media,  presby-
usis,  exposure  to  ototoxic  medication,  chronic  exposure  to
ntense  noise,  cardiovascular  disease  or  chronic  neurolog-
cal  disease.  Clinical  and  demographic  characteristics  and
isease  activity  were  taken  from  the  medical  records,  along
ith  age,  how  long  they  had  been  diagnosed  with  rheuma-
oid  arthritis,  treatment  and  current  dosage;  number  of
nﬂamed,  painful  joints;  visual  analogue  scale:  speed  of
lobular  sedimentation;  rheumatoid  factor:  C-reactive  pro-
ein  and  presence  of  anti-CCP  antibodies.  All  patients  were
lso  in  possession  of  clinical  hearing  records  and  both  tym-
anic  membranes  presented  as  normal  under  examination.
The  control  group  consisted  of  75  volunteers  with  a  sim-
lar  age  and  gender  distribution,  who  presented  without
athology  in  the  hearing  examination,  as  normal  during
ympanometry  and  who  were  without  occupational  noise
xposure.
earing  test
he  audiometric  study  was  carried  out  with  an  Acoustic  Sys-
ems  soundproof  camera,  model  RE-142  manufactured  in
.S.A.,  and  (Interacustic  AC40)  audiometry  and  (Audiotest
25  h  Interacustic)  tympanometry  which  measured  air
onduction  thresholds  at  125--16,000  Hz  frequencies  and
one  conduction  thresholds  at  500--4000  Hz  frequencies.
ure-tone  speech  audiometry  was  used  measuring  speech
iscrimination  thresholds  (speech  audiometry)  and  word
ecognition.  Tympanometry  with  acoustic  reﬂex  and  static
coustic  compliance  for  both  ears  was  used.
Normal  hearing  was  deﬁned  as  the  limit  of  percep-
ion  under  20  decibels  (dB)  at  all  frequencies  and  also
he  type  of  auditive  threshold  and  verbal  discrimination
ccording  to  the  classiﬁcation  by  the  American  Academy
f  Otolaryngology  Committee  on  Hearing  and  Equilibrium.140  dB  was  accepted  as  the  maximum  hearing  loss  threshold
t  16,000  Hz.  Tympanometry  was  considered  normal  with
iddle  ear  pressures  of  ±  75  da  Pa  (deca  Pascal:  unit  of
ressure),  compliance  at  0.28--1.5  ml,  and  acoustic  reﬂex
w
o
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as  considered  normal  when  it  occurred  with  stimulation  at
0--95  dB  in  500;  1000;  2000;  and  4000  Hz.
tatistical  analysis
esults  were  collected  on  an  Excel  database  programme,
ith  analysis  performed  using  the  IBM  SPSS  20  programme.
he  p  <  0.05  value  was  considered  signiﬁcant.  From  all  the
ariables  assessed  traditional  descriptive  statistics  such  as
easures  of  central  tendency,  dispersion  and  position  in  the
ase  of  quantitative  variables  and  measures  of  observed
requencies  in  qualitative  type  variables  were  obtained.
tudy  values  were  segmented  according  to  the  presence  or
bsence  of  hearing  loss,  contrasted  using  hypothesis  testing
or  means  and  proportions,  depending  on  the  case  for  each
ype  of  variable  (quantitative  and  qualitative,  respectively)
t  a  conﬁdence  level  of  95%;  determination  of  association,
orrelation  and  risk  was  determined  by  2,  Pearson  or  Spear-
an  at  the  same  conﬁdence  level.
The  study  was  submitted  to  the  Committee  for  Ethics  and
esearch  of  the  University  Hospital  and  registered  with  the
ey  OT13-005;  no  conﬂict  of  interests  arose.
esults
he  group  under  study  comprised  a  female  population  of  117
atients  (234  hearing  tests  were  carried  out)  aged  between
9  and  65  (with  a  mean  age  of  47.49  ±  11.25),  and  in  8
6.84%)  patients  hearing  was  normal.  Sensorineural  hear-
ng  loss  was  observed  at  high  frequencies  in  109  (93.16%)
atients;  a  prevalence  of  sensorineural  hearing  loss  was
oted  for  frequencies  of  up  to  8000  Hz  in  43.59%  and  for  high
requencies  in  94.02%,  with  frequencies  at  10,000--16,000  Hz
aving  the  highest  effect.  When  the  study  took  place  103
88%)  patients  were  being  treated  with  methotrexate,  63
53.8%)  with  hydroxychloroquine  and  only  37  (31.6%)  with
rednisone.  Length  of  exposure  to  medication  was  reviewed
n  the  medical  records  in  order  to  assess  the  risk  of  ototox-
city  and  no  administration  of  salicylates  was  noted.
Eight  (6.84%)  patients  presented  with  vertigo,  and  24
20.5%)  with  tinnitus,  with  a  bilateral  predominance;  with
espect  to  disease  activity,  63.2%  (74  patients)  presented
 DAS28  over  2.5  and  34.2%  below  this  ﬁgure.  The  joints
f  58.1%  of  patients  were  affected,  41.9%  in  more  than  2
ajor  joints,  17.9%  in  1--3  minor  joints  and  8.5%  in  4--10
oints.  37.6%  of  the  group  studied  had  suffered  from  joint
ymtomatology  for  under  5  years  and  61.4%  for  over  6  years.
Among  the  hearing  characteristics  in  our  study  group  we
bserved  normal  hearing  as  below  20  dB  in  only  8  patients
6.84%),  109  (93.16%)  had  sensorineural  hearing  loss  with-
ut  conductive  system  components,  with  a recording  of  a
igher  effect  at  high  frequencies;  there  was  a symmetri-
al  sensorineural  hearing  loss  in  73  patients  (62.37%),  and
n  asymmetrical  sensorineural  hearing  loss  in  36  (30.77%)
atients.  Of  the  109  patients  with  sensorineural  hearing  loss,
 (1.71%)  presented  with  unilateral  sensorineural  hearing
oss  and  107  (91.45%)  with  bilateral.The  mean  age  of  the  8  patients  with  rheumatoid  arthritis
ith  normal  hearing  was  25.6  whilst  the  mean  age  of  those
ver  31  (109  patients)  with  sensorineural  hearing  loss  was
9.9  (p  <  0.0001).
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Figure  1  Percentage  distribution  of  the  population  under
study according  to  DAS28  activity  grouping.  HA:  high  activity;
Table  1  Averages  and  standard  deviation  in  pure-tone
audiometry  tests  in  medium  frequencies  (500--3000  Hz),
high frequencies  (4000--8000  Hz)  and  very  high  frequencies
(10,000--16,000  Hz)  in  right  and  left  ears  of  patients  with
rheumatoid  arthritis.
Average  of  hearing  threshold  (dB  HL)
Frequency  in  Hz  Right  ear  Left  ear
500--3000  14  ±  6.99  14.5  ±  7.6
4000--8000 22.56  ±  15.5  22.5  ±  15.2
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KLA: low  activity;  MA:  moderate  activity;  R:  remission.  n  =  117
patients.  Source:  clinical  record.  Gr.1.
Patients  were  divided  into  3  age  groups  for  the  study
(under  30,  from  31  to  50  and  from  51  to  65  years  of  age),  and
analysis  was  conducted  of  their  association  or  correlation
with  the  duration  of  their  rheumatoid  arthritis,  body  mass
index,  disease  activity  score  (Fig.  1),  presence  of  anti-CCP
antibodies,  rheumatoid  factor,  C-reactive  protein  (Fig.  2),
ESR  rate,  and  blood  sugar  level.  No  signiﬁcant  differences
were  found.
Hearing  in  both  ears  was  compared  at  frequencies  of
500--3000  Hz,  4000--8000  Hz  and  10,000--16,000  Hz  with  no
signiﬁcant  differences  being  found  and  with  standard  aver-
ages  and  deviations  in  hearing  thresholds  within  the  normal
limits  at  frequencies  of  500--3000  and  at  4000--8000  Hz
of  22.56  ±  15.5  in  the  right  ear  and  22.5  ±  15.2  in  the
left  ear.  The  hearing  threshold  observed  in  frequencies  at
10,000--16,000  Hz  was  48.26  ±  23.23  in  the  right  ear  and
49.24  ±  25.25  in  the  left  ear,  with  hearing  loss  for  these
frequencies  as  observed  in  Table  1.
Hearing  thresholds  were  analysed  for  all  patients  with
rheumatoid  arthritis  and  health  controls  (mean  age  of
32.23  ±  8.82),  comparing  the  right  ear  with  the  left  ear  at
tones  of  500--8000  Hz  with  no  differences  being  observed;
at  frequencies  of  10,000--16,000  Hz  there  was  a  signiﬁcant
difference  of  p  <  0.0001  of  greater  hearing  loss  at  high  fre-
quencies  in  patients  with  rheumatoid  arthritis  vs.  health
control  group,  as  shown  in  Table  2.
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Figure  2  Percentage  distribution  of  the  population  under
study according  to  positive  results  in  the  serological  assess-
ment of  rheumatoid  arthritis  activity.  CCAB:  cyclic  citrullinated
antipeptide  antibody;  RF:  rheumatoid  factor;  CRP:  C-reactive
protein.  n  =  117  patients.  Source:  clinical  record.  Gr.2.
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The  hearing  threshold  was  measured  and  compared  in
requencies  of  125  up  to  16,000  Hz  in  patients  with  rheuma-
oid  arthritis,  with  no  signiﬁcant  differences  being  found  in
he  hearing  levels  of  each  ear  (p  >  0.05).  In  the  middle  ear
e  measured  the  average,  median  and  range  of  levels  of
tatic  compliance  with  a  reporting  of  0.77  ±  0.52  ml  in  the
ight  ear  and  0.78  ±  0.57  ml  in  the  left  ear  with  no  signif-
cant  difference  between  both  ears;  in  the  group  over  50
ears  of  age  a signiﬁcant  difference  of  p  <  0.02  was  found  in
he  right  ear  in  the  discrimination  percentage  in  both  ears
er  age  group.
Tympanometry  of  the  right  ear  showed  a  curve  A  in  91.46%
nd  in  the  left  ear  a  curve  A  in  88.90%  of  patients;  As  (A
hort)  in  the  right  ear  of  5.98%  and  of  10.25%  in  the  left  ear;
d  (A  deep)  in  the  right  ear  of  2.56%  and  0.85%  in  the  left  ear;
here  were  no  patients  with  curve  B  in  our  study.  Auditory
eﬂex  was  present  in  the  right  ear  in  85.2%  of  patients  and
n  the  left  ear  in  75.3%  of  patients,  and  was  only  absent  in
4.8%  and  in  24.7%  respectively  in  our  group  studied.  We
elieve  that  rheumatoid  arthritis  involves  the  transmission
echanisms  of  the  ossicular  chain.
iscussion
astanioudakis  et  al.15 reported  that  sensorineural  hearing
oss  is  mainly  observed  at  low  and  medium  frequencies,
hilst  it  may  be  associated  with  high  frequencies  when  vas-
ulitis  is  present  in  its  ethioipathogenesis.  García  Callejo16
nd  Halligan  et  al.17 reported  a  prevalence  of  sensorineu-
al  hearing  loss  in  patients  with  rheumatoid  arthritis  of
2.7%  and  45%  with  standard  eudiometry  testings  for  fre-
uencies  of  up  8000  Hz;  in  our  study,  similarly  to  the
efore-mentioned  authors,  we  observed  a  prevalence  of
3.59%  at  these  frequencies,  with  a  signiﬁcant  hearing  loss  in
5%  of  patients  at  frequencies  of  10,000--16,000  Hz.  Hearing
oss  observed  was  greater  than  at  20  dB,  with  loss  being  char-
cteristically  symmetrical  and  bilateral  as  shown  in  Fig.  3;
t  is  possible  that  these  results  are  due  to  the  fact  that  the
heumatoid  arthritis  is  systemic  and  affects  both  ears.
In  our  study,  symptomatic  sensorineural  hearing  loss  was
bserved  in  20.5%  of  the  patients  studied,  comparable  with
he  references.  In  our  study  8  patients  presented  with  ver-
igo  (6.8%),  24  (20.5%)  with  tinnitus.  This  was  bilateral  in  14
11.9%)  and  unilateral  in  10  (8.5%).  We  did  not  ﬁnd  any  cases
f  occular  disease  suggestive  of  Cogan  syndrome.
Several  authors  describe  sensorineural  hearing  loss,  par-
icularly  at  high  frequencies.18 In  our  study  we  observed
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Table  2  And  standard  deviation  in  pure-tone  audiometry  tests  in  medium  and  high  frequencies  (500--8000  Hz)  and  very  high
frequencies (10,000--16,000  Hz)  in  right  and  left  ears  in  patients  with  rheumatoid  arthritis  and  health  controls.
Average  of  hearing  threshold  (dB  HL)
Patients  with  rheumatoid  arthritis  (n  =  117)  Health  controls  (n  =  75)
Frequencies  in  Hz Frequencies  in  Hz
500--8000  10,  000--16,  000  500--8000  10, 000--16,  000
Right ear  18.28  ±  11.24  48.26  ±  23.23  12.79  ±  2.52  23.72  ±  10.60
Left ear  18.52  ±  11.41  49.24  ±  25.25  12.95  ±  2.95  22.27  ±  10.49
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St Student test p < 0.0001.
hat  sensorineural  hearing  loss  was  present  at  high  frequen-
ies.  The  hearing  thresholds  were  compared  from  125  to
6,000  Hz  measuring  up  to  the  limits  of  the  audiometry,  with
ild  hearing  loss  at  thresholds  of  4000--8000  Hz  (standard
verage  and  deviation  of  22.56  ±  15.5  dB),  compared  with
earing  thresholds  at  frequencies  of  10,000--16,000  Hz
48.26  ±  23.23  dB),  with  43.6%  of  sensorineural  hearing
oss  detected  in  conventional  audiometry  at  thresholds  of
25--8000  Hz  and  95.7%  at  thresholds  of  10,000--16,000  Hz.
earing  thresholds  were  compared  at  all  frequencies  in  the
ight  and  left  ear,  with  no  statistically  signiﬁcant  ﬁndings
eing  found  between  the  right  and  left  ear.  By  age  group,  in
atients  under  30  years  of  age  it  was  observed  that  with  the
onventional  audiometry  no  sensorineural  hearing  loss  was
ecorded,  in  contrast  to  the  audiometry  at  high  frequencies
hich  detected  hearing  loss  in  66.6%  (7  patients)  at  that
ime;  in  the  group  aged  between  31  and  50  sensorineural
earing  loss  was  observed  with  conventional  audiometry  in
0.9%  vs.  high  frequency  audiometry  in  96.3%  (56  patients)
nd  in  the  51--65  age  group  with  conventional  audiometry  in
4.15%  vs.  98.1%  (54  patients).
Although  several  authors  highlight  the  sensorineural
ature  of  the  hearing  loss,  others  consider  the  middle  ear
19,20 21o  be  the  primary  disease  target. Hüttenbrink refers
o  degenerative  changes  which  have  taken  place  in  the
ncus  and  malleus  joints  and  which  may  alter  the  ossicular
unction  in  response  to  pressure  changes  in  the  middle  ear,
t
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igure  3  Average  distribution  of  decibel  in  the  hearing  threshold
ource: audiometry.ith  protection  mechanisms  possibly  being  reduced  as  a
esult.21--23 In  our  study  the  average,  median  and  range
f  levels  of  static  compliance  were  measured,  reporting
.77  ±  0.52  ml  in  the  right  ear  and  0.78  ±  0.57  ml  in  the  left
ar  without  any  signiﬁcant  difference  between  both  ears.
he  As  curve  in  the  tympanogram  reﬂects  part  of  the  func-
ional  status  of  the  tympanic  membrane  and  ossicular  chain,
hich  increases  in  patients  with  rheumatoid  arthritis.  In  our
esults,  the  graph  in  the  tympanometry  revealed  curve  As
nly  in  7  right  ears  (5.98%)  and  12  left  ears  (10.2%),  and  curve
 in  91.4%  of  right  ears  and  88.9%  of  left  ears.  Acoustic  reﬂex
as  present  in  99  right  ears  (85.2%)  and  88  left  ears  (75.3%),
bsent  in  18  right  ears  14.8%)  and  29  left  ears  (24.7%),  which
eans  that  there  are  few  patients  with  rheumatoid  arthritis
ho  present  with  involvement  of  the  ossicular  chain.
Other  research  studies  reported  a  link  between  sen-
orineural  hearing  loss  and  disease  activity24,25; in  this  study
8.3%  had  positive  rheumatoid  factors,  57.26%  reactive-C
rotein,  47.01%  presence  of  anti-CCP  antibodies;  DAS28  with
ow  (34.2%),  medium  (28.8%),  high  (29.9%)  and  very  high
14.5%)  activity,  with  a  limited  value  in  the  diagnosis  of
uto-immune  disease  of  the  inner  ear  and  no  statistical  sig-
iﬁcance  relating  to  sensorineural  hearing  loss  (p  >  0.05).In  our  study  out  of  117  patients,  103  (88.0%)  were  being
reated  with  methotrexate,  63  (53.8%)  with  hydroxychloro-
uine  and  64  (54.70)  patients  with  both  drugs.  No  signiﬁcant
totoxicity  relationship  was  found  (p  >  0.05).
10,000   12,000  14,000  16,000  18,000
Right
s  in  both  ears  by  high  frequency  audiometry.  n  =  117  patients.
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Conclusions
The  aim  of  this  study  was  for  early  or  subclinical  iden-
tiﬁcation  of  sensorineural  hearing  loss  in  patients  with
rheumatoid  arthritis.
Sensorineural  hearing  loss  observed  in  hearing  thresholds
at  very  high  frequencies  in  our  sample  population  was  sig-
niﬁcantly  high,  compared  with  the  thresholds  below  8000  Hz
observed  in  the  same  patients  with  rheumatoid  arthritis  and
the  control  group.
Our  results  demonstrate  the  usefulness  of  evaluating
hearing  at  very  high  frequencies,  for  subclinical  detection  of
any  degree  of  alteration  in  the  hearing  in  this  patient  group
with  rheumatoid  arthritis.  Since  the  ﬁndings  from  this  study
did  not  reveal  any  particular  relationship  with  rheumatic
disease  activity  or  any  difference  in  serological  variables
researched,  the  opportunity  exists  for  the  prediction  and
early  treatment  of  some  degree  of  cochlear  injury  prior  to
it  becoming  invasive,  as  development  may  be  unpredictable;
we  therefore  suggest  further  research  be  conducted.
We  agree  with  the  characteristics  of  sensorineural  hear-
ing  loss  in  low  tones  observed  in  several  conditions  such
as  Meniere’s  disease.  Patients  with  rheumatoid  arthritis  are
referred  for  consultation  with  hearing  loss,  and  sensorineu-
ral  hearing  loss  in  these  patients  is  initially  affected  at  very
high  frequencies,  especially  those  above  10,000  Hz.  For  this
reason  we  recommend  that  patients  with  rheumatoid  arthri-
tis  undergo  examination  aimed  at  discovering  the  presence
of  hearing  loss  and  an  audiometry  test  at  high  frequencies,
thus  providing  early  information  of  the  cochlear  function
and  if  sensorineural  hearing  loss  were  to  be  observed,  its
development  could  be  altered,  without  the  need  to  wait
until  it  was  affected  by  medium  frequencies  at  500--3000  Hz
with  its  concomitant  effects  on  communication  and  language
discrimination.
Although  the  purpose  of  our  study  was  not  to  determine
the  casuality  between  rheumatoid  arthritis  and  the  high
incidence  of  hearing  loss  at  high  hearing  thresholds,  this
preliminary  approach  has  enabled  us  to  determine  lines  of
inquiry.  This  is  relevant  because  although  the  condition  at
these  high  frequencies  has  no  impact  on  the  quality  of  life
of  the  patient,  if  untreated,  it  could  be  the  beginning  over
time  of  an  irreversible  hearing  loss  damaging  communication
thresholds.
It  is  probable  that  ﬁndings  from  this  study  may  assist
the  physician  in  using  high  frequency  audiometry  to  inten-
tionally  look  out  for  this  hearing  impairment  in  patients
with  rheumatoid  arthritis,  and  alter  its  development  through
treatment,  thereby  preventing  any  further  impairment.
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